Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 27, 2006

View Archived Issues

Cellular uptake and effect of estrogen on activity of paclitaxel poliglumex studied

Tanabe updates recent pipeline progress

Promising results for novel marine-derived heparanase inhibitor in tumor animal models

Preclinical characterization of two novel antiinflammatory syncretic agents, CRx-102 and CRx-139

Atacicept assessed in rheumatoid arthritis

MK-0524 improves niacin-induced flushing

Phase III studies detail efficacy of CERA in chronic kidney disease patients

Promising results of NVP-TAE226 in preclinical models of glioblastoma

Adalimumab may be effective for the treatment of refractory uveitis

Preclinical observations describe CRD-5's mechanism of action

Endosialin/TEM-1: A novel target for cancer therapeutics

Novel E-selectin antagonist may be useful to prevent vascular damage in diabetes

Small peptide analogues of AFPep synthesized, anticancer activity reported

Xanthine oxidase inhibition by natural decursinol shows benefit in a rat model of hyperuricemia

Data on molecular mechanisms of resveratrol's activity

BioProgress and FMC restructure NRobe technology agreements

Amura's orally active cathepsin K inhibitors show antiosteoclast activity

Enrollment open in relapsing remitting MS study of MBP-8298

Emerging companies showcased at BIO-Europe 2006: Cellerix

New series of synthetic CLIP-derived peptides disclosed in recent patent

New patents report agents for treating neurological disorders

Recent patents describe new agents for diabetes and other endocrine-related disorders

Novel agents with potential use in the treatment of obesity and lipoprotein disorders described

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...